Newbridge Financial Services Group, Inc. Madrigal Pharmaceuticals, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $372 Million
- Q4 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 4,203 shares of MDGL stock, worth $1.37 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
4,203Holding current value
$1.37 Million% of portfolio
0.35%Shares
3 transactions
Others Institutions Holding MDGL
# of Institutions
295Shares Held
21.9MCall Options Held
819KPut Options Held
644K-
Janus Henderson Group PLC London, X02.48MShares$809 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$666 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$662 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$651 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$644 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.58B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...